This year’s conference is going virtual! An entirely virtual format will enable innovative learning opportunities, increased schedule flexibility, and a new level of interaction between regulatory practitioners, industry experts, and government officials. Speakers will analyze the latest commercial issues related to advertising and promotion of human and animal drugs, medical devices, and biologics.
Practical Takeaways: Sessions will explore updated government agency enforcement trends, competitor actions, the current state of unapproved use promotion, patient engagement, management of risk in the current climate, and the increasing challenges of various direct-to-consumer marketing platforms.
Government Speakers: Representatives from various FDA Centers, the Federal Trade Commission, the Department of Health and Human Services Inspector General, and the Department of Justice will provide the latest information on policy, enforcement, and future initiatives.
Peer Interaction: The conference will prioritize virtual learning, engagement, and networking with fellow legal, regulatory, and marketing experts.